AttedTrent V - F^ge 1 
ACRONYMS 
ADA 
adenosine deaminase deficiency 
ASM 
American Society for Microbiology 
BIO 
Biotechnology Industry Organization 
BL 
Biosafety Level 
BMBL 
Biosafety in Microbiological and Biomedical Laboratories 
CF 
cystic fibrosis 
CFTR 
cystic fibrosis transmembrane conductance regulator 
CMV 
human cytomegalovirus 
CNS 
central nervous system 
CRAB 
Committee to Revise Appendix B 
CT 
computer tomography 
DNA 
deoribonucleic acid 
ELSI 
Ethical, Legal and Social Implications 
FDA 
Food and Drug Administration 
GCV 
ganciclovir t 
GTl 
Genetic Therapy, Inc. 
GVHD 
graft versus host disease 
HEPA 
High Efficiency Particulate Air 
HIV 
human immunodeficiency virus 
HLA 
human leukocyte antigen 
HNSCC 
Head and Neck Squamous Cell Carcinoma 
HPV 
human papilloma virus 
HSV 
Herpes simplex virus 
D3C 
Institutional Biosafety Committee 
IL 
interleukin 
IND 
Investigational New Drug 
IRB 
Institutional Review Board 
IU 
infectious units 
LAK 
lymphokine activated killer 
Ml 
microliters 
MOI 
multiplicities of infection 
MRI 
magnetic resonance imaging 
(neo 1 ) 
neomycin resistance 
NIH 
National Institutes of Health 
NIH Guidelines 
NIH Guidelines for Research Involving Recombinant DNA Molecules 
OPRR 
Office for Protection from Research Risks 
ORDA 
Office of Recombinant DNA Activities 
PCR 
polymerase chain reaction 
PEG 
polyethylene glycol 
pfu 
plaque forming units 
PGK 
phosphoglycerate kinase 
PI 
principal investigators 
Recombinant DNA Research, Volume 20 
[525] 
